Andrew Zloza, Ph.D.
Affiliations: | 2006 | Rush University, Chicago, IL, United States |
Area:
Immunology, Virology BiologyGoogle:
"Andrew Zloza"Mean distance: 30533.1
Parents
Sign in to add mentor| Lena Al-Harthi | grad student | 2006 | Rush University | |
| (Evaluating the role of CD4(dim)CD8(bright) T cells in viral immunity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| O'Sullivan JA, Kohlhapp FJ, Zloza A, et al. (2023) Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFβ. International Journal of Molecular Sciences. 24 |
| Kohlhapp FJ, O'Sullivan JA, Moore TV, et al. (2023) NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells. Molecular Immunology. 155: 1-6 |
| Geraghty T, Rajagopalan A, Aslam R, et al. (2020) Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer. Frontiers in Oncology. 10: 748 |
| Newman JH, Chesson CB, Herzog NL, et al. (2019) Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer. Proceedings of the National Academy of Sciences of the United States of America |
| Bommareddy PK, Zloza A, Rabkin SD, et al. (2019) Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma. Oncoimmunology. 8: 1591875 |
| Nikolaev EV, Zloza A, Sontag ED. (2019) Immunobiochemical Reconstruction of Influenza Lung Infection-Melanoma Skin Cancer Interactions. Frontiers in Immunology. 10: 4 |
| Newman J, NeMoyer R, Zloza A, et al. (2019) Double-Humanized Mouse Model to Study Bone Morphogenetic Protein (BMP) Signaling in Tumor Xenografts. Methods in Molecular Biology (Clifton, N.J.). 1891: 257-262 |
| Bommareddy PK, Aspromonte S, Zloza A, et al. (2018) MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation. Science Translational Medicine. 10 |
| Romaguera JE, Lee HJ, Tarapore R, et al. (2018) Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment. British Journal of Haematology |
| Newman JH, Augeri DJ, NeMoyer R, et al. (2018) Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer. Oncogene |